Day 2 Supply & Formulation Excellence Stage
07/10/2026 11:35am - 12:25pm
Contributors
Felicity Thomas : Associate Director of Editorial and Content - The Pharma Navigator
Véronique Henner-Kulkarni : Team lead technical sales pharma/nutra - Shin-Etsu SETylose GmbH
Mohamed Maatallah : Business Director KLK Oleo Life Science - KLK Oleo
George Forrest : CEO & Co-founder - Ibumix
Karunakar Sukuru : Global Vice President, Pharma Product Development & Head of Scientific Advisory - Catalent
Fran Sexton : Advisor-TS/MS Network Materials Management - Eli Lilly
Panel: Are innovation and Excipients Mutually Exclusive?
- How non-accidental excipients are at the crossroads between regulation, return on investment and innovation.
- Why advanced formulations require excipients designed for purpose and why the safety requirements are not a barrier to innovation.
- Are there data gaps in the safety (pharmacovigilance) knowledge of excipients?
- Why we need a positive (and negative) list of excipients and their approved routes of administration.